Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.
about
Inflammation and insulin resistanceGlycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adultsVascular function, inflammation, and variations in cardiac autonomic responses to particulate matter among weldersResidential black carbon exposure and circulating markers of systemic inflammation in elderly males: the Normative Aging StudyHigh-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC studyPancreatic regulation of glucose homeostasisEffects of walking on low-grade inflammation and their implications for Type 2 DiabetesAntidiabetic properties of dietary flavonoids: a cellular mechanism reviewHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsDiabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchExosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosisIs there a relationship between vitamin D with insulin resistance and diabetes mellitus?New insights into insulin: The anti-inflammatory effect and its clinical relevanceInflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysisNitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunctionMetabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesConsiderations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 DiabetesAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetesBlood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart studyOccupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review)Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretionThe effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistanceBET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.Helicobacter pylori infection and diabetes: is it a myth or fact?Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis.Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenariansComparisons of the Postprandial Inflammatory and Endotoxaemic Responses to Mixed Meals in Young and Older Individuals: A Randomised Trial.Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities studyMyeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasoundDifferential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies.Temporal reliability of cytokines and growth factors in EDTA plasma.Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.A Prospective Study of Variability in Glycemic Control during Different Phases of the Menstrual Cycle in Type 2 Diabetic Women Using High Sensitivity C - Reactive Protein.Dipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.Glucose supply and insulin demand dynamics of antidiabetic agents.Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes.Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.
P2860
Q22241893-BD80154C-DD95-40A9-B9E7-46D4E8C236AEQ22250879-156C8BE0-3B6C-4B50-B953-6724F39C00FCQ23921422-7E06FB62-65E4-45DF-BD54-DC3DD7EE636CQ23921425-E2304D92-736A-4929-8CA8-D66105F3376CQ24618394-D9301FE0-33C9-4D83-B016-4BCBBE5F269DQ26766485-97453A94-E0AF-44BB-A666-B670DAD75153Q26769053-3FFF07C0-D135-4D55-86CC-3EB04EE73A6FQ26771961-BD60605C-1047-40FA-8344-6D777E675817Q26774658-B5D43243-1DFA-4D60-9D1B-EC8DC93C2532Q26782844-632A65DA-C559-48F9-A598-E275349C12A1Q26797260-5D802370-053A-407D-AF48-C3119E5BDFFFQ26799249-D3BEF283-7A30-4AFF-BF05-F4A963FBFB72Q26822374-FBF0B0D3-BCD9-400F-8F8F-DC3D1727BFBAQ26829404-5B270299-E382-4A43-AB96-70FFA7830941Q26830607-18365464-A8B4-4668-9025-375E0EAAAA5EQ28066564-CFB9B607-AC90-4F48-B6FD-447BA7EE8B4DQ28073309-F79C9F5B-036B-4CBD-A1F1-D117E28F7C21Q28077101-29A71216-FA05-4BB4-A748-10C68E83C2D7Q28387157-80B42D79-A709-402B-ABDB-FDECA37CBEEAQ28389743-E2AA9461-400B-43E1-80CF-2E2B88DD8CCDQ28582459-6BD88025-1CDD-424B-AC70-C6E7D29291C1Q28588479-D6C16A79-E079-4527-A5A6-7A82B6BC625AQ30009848-37BFB83E-980E-4CFF-9F4A-A97420F051F9Q30248629-095E5C10-02C1-4CF1-8557-2F916D08E682Q30361927-760D014B-3278-4EE4-A786-8A8115145387Q30429027-A299BF9D-5F7A-4E44-B376-0ACEF3843E88Q30583469-C112D648-6175-4DC0-BA84-7FA306139AD3Q33586253-293B14FB-0192-4D1A-A66B-06AD89162FE9Q33616715-853D130A-9843-4A5F-A8BE-C49411CEE4E1Q33668158-E6A021B6-5AD4-47E0-8524-217770B25BF6Q33688005-9E7AD1E3-CC94-4B35-AEC7-0F73969BBE57Q33728315-8C3C6708-6229-4840-8590-540660242D35Q33745785-4FAD553D-8B6F-4302-9A67-0247714C7573Q33767803-F400BD9F-ADB5-43EA-921A-EF0433EAA8DDQ33783447-666BDBA0-3F10-4A28-9308-7EFBE85CEA39Q33804704-D34ACAA6-26BA-4969-9B8B-4E1938DBACCDQ33828255-0087E8F2-AD7A-49EB-9F59-25D2C06C30A1Q33862296-907FABDD-E4C3-4A4D-AAED-D67730808255Q33901576-27250DBB-FC88-46A5-BE86-6D81394191E0Q33932928-EADA93A0-34B1-4955-9B44-09913150B6D8
P2860
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Low-grade systemic inflammatio ...... sis risk in communities study.
@en
Low-grade systemic inflammatio ...... sis risk in communities study.
@nl
type
label
Low-grade systemic inflammatio ...... sis risk in communities study.
@en
Low-grade systemic inflammatio ...... sis risk in communities study.
@nl
prefLabel
Low-grade systemic inflammatio ...... sis risk in communities study.
@en
Low-grade systemic inflammatio ...... sis risk in communities study.
@nl
P2093
P50
P921
P1433
P1476
Low-grade systemic inflammatio ...... sis risk in communities study.
@en
P2093
Alvaro Vigo
Atherosclerosis Risk in Communities Study
Bruce B Duncan
Christie M Ballantyne
David Couper
Maria Inês Schmidt
P304
P356
10.2337/DIABETES.52.7.1799
P407
P577
2003-07-01T00:00:00Z